Report - Medical Technology M&A Review Q1 2015 EV/EBITDA multiples for the OMD comparables in Q1 2015 were 13.4x, a decrease from 14.0x in Q4 2014 but comparable to Q1 2014. Average EV/Revenue

Please pass captcha verification before submit form